Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Jan. 31, 2019. Julie Khani.

Executive Summary

Sen. Chuck Grassley cites a US Government Accountability Office analysis in arguing the Medicare agency may be preparing to overpay clinical labs, but the lab industry says GAO is misguided. See what the American Clinical Laboratory Association's Julie Khani has to say about it here.

“GAO concocts a hypothetical scenario that suggests labs are unbundling these tests and receiving higher reimbursement – this is grossly inaccurate.” – Julie Khani, president, American Clinical Laboratory Association

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT124568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel